Cargando…
Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of t...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452463/ https://www.ncbi.nlm.nih.gov/pubmed/30997084 http://dx.doi.org/10.1002/ccr3.2090 |